Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The Future of Drug Regulation: An Interview With Center for Drug Evaluation & Research Director Janet Woodcock

This article was originally published in RPM Report

Executive Summary

FDA’s top drug regulator sat down for us for an interview about the agency’s efforts to build a higher quality regulatory system in the US—one that focuses on the “content” of regulatory standards rather than just the process. The discussion touched on the need for new and improved standards in classes like weight loss and rheumatology (albeit for very different reasons); the characteristics that make for good drug reviewers (and their managers); and on the drug center’s responsibility for preserving private sector drug development.
Advertisement

Related Content

FDA Eager For More Master Protocols in Oncology: Approach Means Lower Cost For Sponsors—and Less Control
FDA Rethinking Weight Loss Standards: A Test Case for Patient-Focused Drug Development
A Case Study in Regulatory Innovation: Pharmacogenomics at FDA
FDA and the R&D Crisis: Time to Stop the Blame Game
How FDA Withdraws A Drug
The FDA Roundtable Part II: REMS, Outcomes Studies and Drug Withdrawals
The FDA Roundtable Part I: The Regulators' View of Drug Development
How FDA Makes Tough Decisions

Topics

Advertisement
UsernamePublicRestriction

Register

PS080857

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel